Academic Journal

MGMT activated by Wnt pathway promotes cisplatin tolerance through inducing slow-cycling cells and nonhomologous end joining in colorectal cancer

التفاصيل البيبلوغرافية
العنوان: MGMT activated by Wnt pathway promotes cisplatin tolerance through inducing slow-cycling cells and nonhomologous end joining in colorectal cancer
المؤلفون: Haowei Zhang, Qixin Li, Xiaolong Guo, Hong Wu, Chenhao Hu, Gaixia Liu, Tianyu Yu, Xiake Hu, Quanpeng Qiu, Gang Guo, Junjun She, Yinnan Chen
المصدر: Journal of Pharmaceutical Analysis, Vol 14, Iss 6, Pp 100950- (2024)
بيانات النشر: Elsevier, 2024.
سنة النشر: 2024
المجموعة: LCC:Therapeutics. Pharmacology
مصطلحات موضوعية: Colorectal cancer, MGMT, Chemotherapy resistance, Slow-cycling cells, Nonhomologous end joining, Wnt pathway, Therapeutics. Pharmacology, RM1-950
الوصف: Chemotherapy resistance plays a pivotal role in the prognosis and therapeutic failure of patients with colorectal cancer (CRC). Cisplatin (DDP)-resistant cells exhibit an inherent ability to evade the toxic chemotherapeutic drug effects which are characterized by the activation of slow-cycle programs and DNA repair. Among the elements that lead to DDP resistance, O6-methylguanine (O6-MG)-DNA-methyltransferase (MGMT), a DNA-repair enzyme, performs a quintessential role. In this study, we clarify the significant involvement of MGMT in conferring DDP resistance in CRC, elucidating the underlying mechanism of the regulatory actions of MGMT. A notable upregulation of MGMT in DDP-resistant cancer cells was found in our study, and MGMT repression amplifies the sensitivity of these cells to DDP treatment in vitro and in vivo. Conversely, in cancer cells, MGMT overexpression abolishes their sensitivity to DDP treatment. Mechanistically, the interaction between MGMT and cyclin dependent kinase 1 (CDK1) inducing slow-cycling cells is attainted via the promotion of ubiquitination degradation of CDK1. Meanwhile, to achieve nonhomologous end joining, MGMT interacts with XRCC6 to resist chemotherapy drugs. Our transcriptome data from samples of 88 patients with CRC suggest that MGMT expression is co-related with the Wnt signaling pathway activation, and several Wnt inhibitors can repress drug-resistant cells. In summary, our results point out that MGMT is a potential therapeutic target and predictive marker of chemoresistance in CRC.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2095-1779
Relation: http://www.sciencedirect.com/science/article/pii/S2095177924000388; https://doaj.org/toc/2095-1779
DOI: 10.1016/j.jpha.2024.02.004
URL الوصول: https://doaj.org/article/a38d5429bf674691944dd9a34420af31
رقم الانضمام: edsdoj.38d5429bf674691944dd9a34420af31
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:20951779
DOI:10.1016/j.jpha.2024.02.004